Information for:

Resources

Jin-Xiong She

Director

Jin-Xiong She

Director

Professor

Academic Appointment(s)

Medical College of Georgia
Department of Obstetrics and Gynecology

College of Allied Health Sciences
Department of Medical Laboratory, Imaging and Radiologic Sciences

The Graduate School

Other Duties

Eminent Scholar Chair in Genomic Medicine, Center for Biotechnology and Genomic Medicine

  • (706) 721-3410
  • (706) 721-3688
  • CA II 4126

Education

  • Ph.D., Biochemistry University of Montpellier, 1987

  • MS, Fishing and Fisheries Sci and National School of Agriculture, 1984

  • BS, Fishing and Fisheries Sci and Agric Col of Central China, 1982

Courses Taught Most Recent Academic Year

  • GNMD 9300

    Research in Genomic Medicine

  • GNMD 8060

    Genomic Medicine Seminar

  • GNMD 9210

    Inves of a Prob Genomic Med

  • GNMD 8051

    Translational Genom/Proteomic

  • GNMD 8052

    Func Geno & Prote Using Anml M

  • MEDI 5088

    Medical Scholars Program

Scholarship

Selected Recent Publications

  • Factors that Increase Risk of Celiac Disease Autoimmunity Following a Gastrointestinal Infection in Early Life., 2016
    Journal Article, Academic Journal
  • Reversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study., 2016
    Journal Article, Academic Journal
  • Co-targeting EGFR and survivin with a bivalent aptamer-dual siRNA chimera effectively suppresses prostate cancer., 2016
    Journal Article, Academic Journal
  • Growth and Risk for Islet Autoimmunity and Progression to Type 1 Diabetes in Early Childhood: The Environmental Determinants of Diabetes in the Young Study., 2016
    Journal Article, Academic Journal
  • Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study., 2016
    Journal Article, Academic Journal

Research Interests

Dr. She's research focuses on the development and application of high throughput technologies (Genomics, Transcriptomics, Proteomics, Glycomics, Bioinformatics, Drug Screening and Drug Design) for biomarker discovery and novel intervention strategies for autoimmune diseases, diabetic complications and various types of cancer.